Pharmaceuticals

Global Antiglaucoma Drugs Market Size, Forecasts, And Opportunities

December 27, 2021 by The Business Research Company

Learn about the global antiglaucoma drugs market through The Business Research Company, which provides information on antiglaucoma drugs market size, antiglaucoma drugs market drivers and restraints, antiglaucoma drugs market players, the COVID-19 impact on the antiglaucoma drugs market, and more.

Last chance at deals on TBRC’s market research reports! Get the best offer today.

The global antiglaucoma drugs market is expected to grow from $5.76 billion in 2020 to $6.47 billion in 2021 at a compound annual growth rate (CAGR) of 12.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $8.17 billion in 2025 at a CAGR of 6%.

Incidence of glaucoma increases with age and due to increase in the geriatric population worldwide, governments are launching initiatives to promote awareness on glaucoma and other eye disorders.

Request A Sample For The Global Antiglaucoma Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3803&type=smph

The antiglaucoma drug market consists of sales of antiglaucoma drugs which are used in the treatment of glaucoma. Glaucoma is a disease in which the optic nerve is damaged resulting into irreversible loss of vision and it is often associated with increased pressure of the fluid in eye. The market comprises of segments such as alpha agonists, beta blockers, prostaglandins, combined medication and other. The market does not include the sale of biologics used for the treatment of glaucoma.

Global Antiglaucoma Drugs Market Segments Include:

By Product Type: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others

By Disease Condition Type: Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma

By Type: Hospital Prescription Drugs, Over-The-Counter Drugs

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Companies in the antiglaucoma drugs market are developing combination therapies in the treatment of glaucoma disease due to their ability to lower intraocular pressure in glaucoma patients. Most of the combinations therapies are fixed dose drugs as it offers patient the ease of consumption when compared to non-fixed combinations.

TBRC’s antiglaucoma drugs market report covers:

Major Market Players: Aerie Pharmaceuticals, Inc., Allergan, Novartis AG, Abbott Healthcare and Johnson & Johnson.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Antiglaucoma Drugs Global Market Report 2021: COVID-19 Impact And Recovery to 2030 is one of a series of new reports from The Business Research Company that provides antiglaucoma drugs market overviews, analyses and forecasts market size, share, antiglaucoma drugs market players, antiglaucoma drugs market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s antiglaucoma drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Dry Eye Medication Market

Ophthalmology Drugs Market

Vision Care Devices And Equipment Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model